Biologic agents (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
46 | Malignant rheumatoid arthritis | 2 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02311855 (ClinicalTrials.gov) | August 2014 | 4/12/2014 | Duration of Immune Response to Influenza Vaccination in Patients With RA | Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents | Rheumatoid Arthritis | Biological: Influenza vaccine | Bassett Healthcare | New York State Department of Health | Completed | 40 Years | 75 Years | All | 87 | Phase 4 | United States |
2 | NCT03496831 (ClinicalTrials.gov) | January 1, 2006 | 5/4/2018 | Predicting Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs | Development of a Prediction Model for the Risk of Hospitalized Infection in Patients With Chronic Inflammatory Arthritis Treated With Biological Drugs | Rheumatoid Arthritis;Spondyloarthritis;Psoriatic Arthritis | Drug: Biologic Agents | Simon Krabbe | University of Aarhus;Zealand University Hospital;University of Southern Denmark | Completed | 18 Years | N/A | All | 7500 | NULL |